July 1st, 2008

It’s a . . . System

By Bill

Melissa Katz, formerly of CNTO411 fame, is now global director of Corporate Communications at Animas, and she just can’t get that blogging bug out of her system. 😉

Today, she offers this post to JNJBTW about some exciting news in the diabetes care world.

Welcome back, Melissa.

Animas, Johnson & Johnson’s insulin pump company, is proud to welcome the newest member of our family, OneTouch® Ping™ glucose management system (see picture: awwww!!).
OneTouch Ping

In partnership with our sister company, LifeScan, we have managed to link the full-feature Animas insulin pump with the world’s leading OneTouch meter, but this time, they talk to each other! Not only that, you can use the meter as a remote control. Cool, huh?

One of the biggest issues facing people with Type 1 diabetes is that everybody knows your business. Sitting at a meal with friends, if a pumper needs to give herself insulin, she takes out the pump and programs it. The folks in our R&D group (imagine them hanging out playing ping-pong in the “Innovation Room” coming up with new ways to help our pumpers) thought, wouldn’t it be great if she could control her pump remotely to make it more discreet?

With OneTouch Ping, that pumper can leave her pump on her belt or in her tank top and just tell it what to do with a device the size of a cell phone or BlackBerry. Same goes for the mom of the 4 year-old type 1 child who catches him at a birthday party to test his blood sugar. Now, she can give him insulin remotely from the meter as he’s running back to the moon bounce. It may seem like a little thing, but when you have diabetes 24 hours a day, 7 days a week for a lifetime, it makes a difference.

Check out the news at www.animascorp.com where you can hear from our pumpers about why insulin therapy was right for them.

Thanks for all your kind wishes. We’re so proud of our growing family.

Leave a Reply

All comments will be reviewed before posting. Since this blog is about Johnson & Johnson, comments that don’t directly relate to the Company or to topics covered on this blog won’t be posted. Please see our comments policy for details.